Envision by InMode is an advanced, non-invasive platform specifically designed to treat dry eye disease by addressing its underlying causes.
The system integrates two cutting-edge technologies: Forma-I and Lumecca-I.
Forma-I employs bipolar radiofrequency (RF) energy to safely heat the meibomian glands, facilitating the release of trapped oils and enhancing tear film stability. This process also stimulates collagen production, reducing inflammation and promoting overall ocular health.
Lumecca-I uses intense pulsed light (IPL) therapy to target inflammation, ocular rosacea, and Demodex infestations – conditions often associated with dry eye. By penetrating deeper into the skin’s layers, Lumecca-I effectively reduces abnormal blood vessels and alleviates inflammation.
Together, these technologies offer a comprehensive, personalised treatment that provides long-lasting relief from dry eye symptoms, improving patients’ vision and quality of life.
Visit: inmode.com.au
